Timing, delays and pathways to diagnosis of endometriosis: a scoping review protocol.
Timing, delays and pathways to diagnosis of endometriosis: a scoping review protocol.
复制标题
DOI：
10.1136/bmjopen-2021-049390
复制
发表时间：
2021-06-24
期刊：
影响因子：
2.9
通讯作者：
Thoyre S
中科院分区：
文献类型：
--
作者：
Cromeens MG;Carey ET;Robinson WR;Knafl K;Thoyre S
子宫内膜异位症女性的诊断途径常常存在延迟。在国际上，女性面临着巨大的障碍和诊断时间。长时间未得到诊断可能会导致治疗延迟，并产生慢性疼痛的临床影响以及对生育结果的未知影响。随着诊断延迟的延长，子宫内膜异位症患者会承担更多的费用，并且生活质量常常会下降。本协议中描述的范围界定审查将（1）绘制当前国际科学同行评审和灰色文献，调查子宫内膜异位症诊断的途径、时间和延迟，（2）定义文献中使用的常见概念，（3）确定未来检查和干预发展的差距。该协议概述了一项范围审查，以调查当前研究的重点是子宫内膜异位症诊断的途径、时间和延迟。范围界定审查使用乔安娜·布里格斯研究所方法论。研究人员应用总体、概念、背景方法来形成研究问题。关键术语和医学主题标题的搜索字符串将用于系统地搜索 PubMed、CINAHL、EMBASE、Web of Science 和 Cochrane 数据库。我们还将搜索 ClinicalTrials.gov 和灰色文献来源。最初的检索于 2020 年 7 月进行，并将在稿件提交之前重新运行。最后，将审查所包含作品的参考列表以进行进一步的研究。搜索结果将根据预定的纳入和排除标准进行筛选和审查。数据将从使用预定工具确定最终纳入的研究中提取。将分析所得数据以报告科学状况。拟议的范围界定审查不需要道德委员会的审查或批准。研究人员将通过会议演讲和在同行评审期刊上发表文章来传播研究结果。
Pathways to diagnosis for women with endometriosis are frequently characterised with delays. Internationally, women face significant barriers and times to diagnosis. The prolonged time without a diagnosis may result in treatment delay, with clinical implications of chronic pain and an unknown effect on fertility outcomes. As delays in diagnosis extend, those suffering from endometriosis incur more cost and frequently experience a reduction in quality of life. The scoping review described in this protocol will (1) map current international scientific peer-reviewed and grey literature investigating pathways, timing, and delay of diagnosis of endometriosis, (2) define common concepts used in the literature, and (3) identify gaps for future examination and intervention development. This protocol outlines a scoping review to investigate the current research focused on pathways, timing, and delays in endometriosis diagnosis. The scoping review uses the Joanna Briggs Institute Methodology. The researchers applied the Population, Concept, Context approach to form the research questions. A search string of key terms and Medical Subject Headings will be used to systematically search the PubMed, CINAHL, EMBASE, Web of Science, and Cochrane databases. We will also search ClinicalTrials.gov and grey literature sources. The original search was performed in July 2020, and it will be rerun prior to the manuscript submission. Finally, the reference lists of included works will be reviewed for additional studies. The search results will be screened and reviewed according to predetermined inclusion and exclusion criteria. Data will be extracted from the studies identified for final inclusion using a predetermined tool. The resulting data will be analysed to report the state of the science. The proposed scoping review does not require review or approval by an ethical board. The researchers will disseminate the study results via conference presentations and publication in a peer-reviewed journal.
登录
查看更多内容
影响因子：
3.8
作者：
Soliman AM;Surrey E;Bonafede M;Nelson JK;Castelli-Haley J
通讯作者：
Castelli-Haley J
影响因子：
4
作者：
Bajaj, P;Bajaj, P;Arendt-Nielsen, L
通讯作者：
Arendt-Nielsen, L
DOI：
10.1016/j.ejogrb.2016.07.497
发表时间：
2017-02-01
影响因子：
2.6
作者：
Morotti, Matteo;Vincent, Katy;Becker, Christian M.
通讯作者：
Becker, Christian M.
影响因子：
13.3
作者：
Stratton, Pamela;Berkley, Karen J.
通讯作者：
Berkley, Karen J.
影响因子：
6.7
作者：
Nnoaham, Kelechi E.;Hummelshoj, Lone;Webster, Premila;d'Hooghe, Thomas;Nardone, Fiorenzo de Cicco;Nardone, Carlo de Cicco;Jenkinson, Crispin;Kennedy, Stephen H.;Zondervan, Krina T.
通讯作者：
Zondervan, Krina T.